600763 通策医疗
已收盘 05-07 15:00:00
资讯
新帖
简况
每周股票复盘:通策医疗(600763)蒲公英医院2026年目标营收增48%
证券之星 · 04-26
每周股票复盘:通策医疗(600763)蒲公英医院2026年目标营收增48%
国金证券:给予通策医疗增持评级
证券之星 · 04-23
国金证券:给予通策医疗增持评级
股市必读:通策医疗(600763)4月21日披露最新机构调研信息
证券之星 · 04-22
股市必读:通策医疗(600763)4月21日披露最新机构调研信息
通策医疗:华创证券、天风证券等多家机构于4月20日调研我司
证券之星 · 04-21
通策医疗:华创证券、天风证券等多家机构于4月20日调研我司
“牙茅”通策医疗2025年营收、利润微增,6亿收购实控人眼镜公司遭问询
蓝鲸财经 · 04-21
“牙茅”通策医疗2025年营收、利润微增,6亿收购实控人眼镜公司遭问询
开源证券:给予通策医疗买入评级
证券之星 · 04-21
开源证券:给予通策医疗买入评级
通策医疗(600763)披露2025年利润分配公告,4月20日股价下跌0.34%
证券之星 · 04-20
通策医疗(600763)披露2025年利润分配公告,4月20日股价下跌0.34%
业绩增长乏力,“牙茅”通策医疗押注眼科前景几何
市场资讯 · 04-19
业绩增长乏力,“牙茅”通策医疗押注眼科前景几何
每周股票复盘:通策医疗(600763)一季度净利增1.66%
证券之星 · 04-19
每周股票复盘:通策医疗(600763)一季度净利增1.66%
通策医疗(600763)3月31日股东户数9.05万户,较上期增加2.32%
证券之星 · 04-18
通策医疗(600763)3月31日股东户数9.05万户,较上期增加2.32%
图解通策医疗一季报:第一季度单季净利润同比增长1.66%
证券之星 · 04-18
图解通策医疗一季报:第一季度单季净利润同比增长1.66%
通策医疗(600763.SH)发布2025年度业绩,归母净利润5.02亿元,同比增长0.19%
智通财经 · 04-17
通策医疗(600763.SH)发布2025年度业绩,归母净利润5.02亿元,同比增长0.19%
通策医疗(600763)披露拟6亿元收购四家眼视光公司股权,4月7日股价上涨0.44%
证券之星 · 04-07
通策医疗(600763)披露拟6亿元收购四家眼视光公司股权,4月7日股价上涨0.44%
每周股票复盘:通策医疗(600763)拟6亿收购杭州存济眼镜
证券之星 · 04-05
每周股票复盘:通策医疗(600763)拟6亿收购杭州存济眼镜
通策医疗(600763)披露拟6亿元收购杭州存济眼镜100%股权公告,4月2日股价下跌2.19%
证券之星 · 04-02
通策医疗(600763)披露拟6亿元收购杭州存济眼镜100%股权公告,4月2日股价下跌2.19%
通策医疗(600763)披露2026年独立董事专门会议第一次会议审核意见,3月24日股价上涨1.62%
证券之星 · 03-24
通策医疗(600763)披露2026年独立董事专门会议第一次会议审核意见,3月24日股价上涨1.62%
通策医疗最新公告:拟6亿元收购四家眼视光公司100%股权
证券之星 · 03-24
通策医疗最新公告:拟6亿元收购四家眼视光公司100%股权
通策医疗(600763.SH)部分董事及高管拟600万元至1200万元增持公司股份
智通财经 · 02-23
通策医疗(600763.SH)部分董事及高管拟600万元至1200万元增持公司股份
1月29日通策医疗涨5.14%,广发聚瑞混合A基金重仓该股
证券之星 · 01-29
1月29日通策医疗涨5.14%,广发聚瑞混合A基金重仓该股
通策医疗(600763)披露关于选举职工董事及取消职工监事的公告,12月10日股价下跌0.77%
证券之星 · 2025-12-10
通策医疗(600763)披露关于选举职工董事及取消职工监事的公告,12月10日股价下跌0.77%
加载更多
公司概况
公司名称:
通策医疗股份有限公司
所属行业:
卫生
上市日期:
1996-10-30
主营业务:
通策医疗股份有限公司的主营业务是医疗器械、日用品、消毒用品的销售,投资管理,经营进出口业务,技术开发、技术咨询和技术服务,培训服务(不含办培训班)。公司的主要产品是医疗服务、产品销售、建设工程。公司连续七年(2018-2024年)获评德勤中国“中国卓越管理公司”,并于2025年荣膺该评选的“白金奖”、2026年获“杭州上城区经济高质量发展先进集体”,旗下杭州口腔医院荣获2025年度杭州市政府质量奖。
发行价格:
4.08
{"stockData":{"symbol":"600763","market":"SH","secType":"STK","nameCN":"通策医疗","latestPrice":41.77,"timestamp":1778137200000,"preClose":42.41,"halted":0,"volume":8572387,"delay":0,"changeRate":-0.0151,"floatShares":447000000,"shares":447000000,"eps":1.1288,"marketStatus":"已收盘","change":-0.64,"latestTime":"05-07 15:00:00","open":42.41,"high":42.61,"low":41.55,"amount":359000000,"amplitude":0.025,"askPrice":41.77,"askSize":366,"bidPrice":41.76,"bidSize":85,"shortable":0,"etf":0,"ttmEps":1.1288,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778203800000},"marketStatusCode":5,"adr":0,"adjPreClose":42.41,"symbolType":"stock","openAndCloseTimeList":[[1778117400000,1778124600000],[1778130000000,1778137200000]],"highLimit":46.65,"lowLimit":38.17,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":447289117,"isCdr":false,"pbRate":4.23,"roa":"--","peRate":37.003898,"roe":"4.32%","epsLYR":1.12,"committee":-0.337963,"marketValue":18683000000,"turnoverRate":0.0192,"status":1,"floatMarketCap":18683000000},"requestUrl":"/m/hq/s/600763","defaultTab":"news","newsList":[{"id":"2630809088","title":"每周股票复盘:通策医疗(600763)蒲公英医院2026年目标营收增48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630809088","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630809088?lang=zh_cn&edition=full","pubTime":"2026-04-26 01:47","pubTimestamp":1777139229,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘,通策医疗报收于43.23元,较上周的41.21元上涨4.9%。本周,通策医疗4月24日盘中最高价报44.5元。本周关注点来自机构调研要点:蒲公英医院2026年目标整体营收同比增长48%。全年门诊量 357.36 万人次,同比增长 1.14%。答:2025 年蒲公英医院共 49家,实现收入 8.56亿元,占公司总营收 31%,同比增长 20%;毛利率 28%,净利润 9236 万元,同比增长 95%。2026 年一季度蒲公英医院营收 2.23 亿元,同比增长 17%;净利润 4400 万元,同比增长 24%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600000541.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629745200","title":"国金证券:给予通策医疗增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2629745200","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629745200?lang=zh_cn&edition=full","pubTime":"2026-04-23 08:05","pubTimestamp":1776902753,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司甘坛焕近期对通策医疗进行研究并发布了研究报告《业绩平稳增长,营销改革有望贡献新增量》,给予通策医疗增持评级。 通策医疗 业绩简评 2026年4月17日,公司发布2025年年报及2026年第一季度报告。经营活动产生的现金流量净额为8.11亿元,同比增长6.2%,经营质量优异。正畸业务2025年收入5.10亿元,同比增长7.63%,正畸业务呈现明确复苏态势。全年病例量同比增长10.8%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300020302.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629054890","title":"股市必读:通策医疗(600763)4月21日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2629054890","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629054890?lang=zh_cn&edition=full","pubTime":"2026-04-22 02:22","pubTimestamp":1776795729,"startTime":"0","endTime":"0","summary":"截至2026年4月21日收盘,通策医疗报收于40.79元,下跌0.68%,换手率1.34%,成交量6.01万手,成交额2.46亿元。2026 年一季度实现营业收入 7.55 亿元,同比增长 1.43%;归母净利润 1.87 亿元,同比增长 1.66%;扣非净利润 1.85亿元,同比增长 1.37%;经营活动现金流 1.61 亿元,同比增长 9.07%。省内医疗服务收入 25.15 亿元,同比增长 2.1%;省外 2.49亿元,同比下降 7.11%。全年门诊量 357.36 万人次,同比增长 1.14%。2026 年一季度蒲公英医院营收 2.23 亿元,同比增长 17%;净利润 4400 万元,同比增长 24%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200005895.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0146","BK0077","BK0048","BK0096","600763","BK0236","BK0284"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629018087","title":"通策医疗:华创证券、天风证券等多家机构于4月20日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2629018087","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629018087?lang=zh_cn&edition=full","pubTime":"2026-04-21 18:19","pubTimestamp":1776766764,"startTime":"0","endTime":"0","summary":"证券之星消息,2026年4月21日通策医疗发布公告称华创证券郑辰 王宏雨、天风证券杨松 刘一伯、中泰证券祝嘉琦 杨涛、东吴证券朱国广 冉胜男、开源证券余汝意 阮帅、中信证券陈竹 宋硕 沈睦钧于2026年4月20日调研我司。通策医疗2026年一季报显示,一季度公司主营收入7.55亿元,同比上升1.43%;归母净利润1.87亿元,同比上升1.66%;扣非净利润1.85亿元,同比上升1.37%;负债率23.29%,投资收益880.6万元,财务费用823.28万元,毛利率43.87%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100042175.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","601162","BK0096","BK0114","161027","BK0276","600763","BK0048","BK0146","BK0236","BK0284"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629566087","title":"“牙茅”通策医疗2025年营收、利润微增,6亿收购实控人眼镜公司遭问询","url":"https://stock-news.laohu8.com/highlight/detail?id=2629566087","media":"蓝鲸财经","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629566087?lang=zh_cn&edition=full","pubTime":"2026-04-21 18:07","pubTimestamp":1776766077,"startTime":"0","endTime":"0","summary":"年报显示,通策医疗营收与净利润均只有微幅增长。而在此背景下,近日,通策医疗披露拟以6亿元现金收购上市公司实控人吕建明控制下的杭州存济眼镜、宁波广济眼视光、杭州广济眼视光、新昌广济眼镜4家眼视光公司,引发上交所发函追问和市场关注。通策医疗预计,杭州存济眼镜近年来各类眼镜销量持续攀升,2026年至2028年的主营业务收入分别将达到1.65亿元、1.77亿元、1.85亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1776765932176249755","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["600763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629736707","title":"开源证券:给予通策医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2629736707","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629736707?lang=zh_cn&edition=full","pubTime":"2026-04-21 14:15","pubTimestamp":1776752116,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司余汝意,阮帅近期对通策医疗进行研究并发布了研究报告《公司信息更新报告:2026Q1业绩稳健增长,期待营销改革落地》,给予通策医疗买入评级。最新盈利预测明细如下:该股最近90天内共有2家机构给出评级,买入评级2家;过去90天内机构目标均价为67.0。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100028866.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","600763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628749044","title":"通策医疗(600763)披露2025年利润分配公告,4月20日股价下跌0.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628749044","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628749044?lang=zh_cn&edition=full","pubTime":"2026-04-20 17:59","pubTimestamp":1776679152,"startTime":"0","endTime":"0","summary":"截至2026年4月20日收盘,通策医疗报收于41.07元,较前一交易日下跌0.34%,最新总市值为183.7亿元。该股当日开盘40.95元,最高41.6元,最低40.38元,成交额达4.11亿元,换手率为2.25%。近日,通策医疗股份有限公司发布《关于2025年利润分配的公告》。公告显示,公司2025年度合并报表归属上市公司股东净利润为501,945,804.29元,母公司累计可供分配利润为1,041,817,621.72元。该利润分配方案尚需提交公司股东会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000026416.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0236","BK0048","600763","BK0114","BK0284","BK0146","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628647207","title":"业绩增长乏力,“牙茅”通策医疗押注眼科前景几何","url":"https://stock-news.laohu8.com/highlight/detail?id=2628647207","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628647207?lang=zh_cn&edition=full","pubTime":"2026-04-19 20:17","pubTimestamp":1776601020,"startTime":"0","endTime":"0","summary":" 4月18日,国内口腔医疗服务龙头企业通策医疗交出了2025年以及2026年一季度的成绩单。近年来,在种植牙集采及口腔医疗市场进入调整期的影响下,通策医疗业绩增长出现乏力迹象。 财务数据显示,通策医疗2025年实现营业收入29.13亿元,同比增长1.37%;归属净利润5.02亿元,同比增长0.19%。 主营业务增长引擎动力不足,通策医疗将目光投向了眼科。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2026-04-19/doc-inhuzxas0334398.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0146","BK0284","600763","BK0077","BK0114","BK0236","BK0096","BK0048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628756439","title":"每周股票复盘:通策医疗(600763)一季度净利增1.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628756439","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628756439?lang=zh_cn&edition=full","pubTime":"2026-04-19 01:45","pubTimestamp":1776534311,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘,通策医疗报收于41.21元,较上周的42.13元下跌2.18%。本周关注点来自业绩披露要点:通策医疗2026年一季度归母净利润1.87亿元,同比上升1.66%。股本股东变化股东户数变动截至2026年3月31日,通策医疗股东户数为9.05万户,较2月10日增加2049户,增幅2.32%。业绩披露要点财务报告通策医疗2026年一季报显示,主营收入7.55亿元,同比上升1.43%;归母净利润1.87亿元,同比上升1.66%;扣非净利润1.85亿元,同比上升1.37%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900000546.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0284","BK0096","BK0236","600763","BK0077","BK0146","BK0048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628373252","title":"通策医疗(600763)3月31日股东户数9.05万户,较上期增加2.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628373252","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628373252?lang=zh_cn&edition=full","pubTime":"2026-04-18 17:03","pubTimestamp":1776503003,"startTime":"0","endTime":"0","summary":"证券之星消息,近日通策医疗披露,截至2026年3月31日公司股东户数为9.05万户,较2月10日增加2049.0户,增幅为2.32%。在医疗服务行业个股中,通策医疗股东户数高于行业平均水平,截至3月31日,医疗服务行业平均股东户数为4.56万户。从股价来看,2026年2月10日至2026年3月31日,通策医疗区间跌幅为13.4%,在此期间股东户数增加2049.0户,增幅为2.32%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041800018472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0077","BK0048","BK0284","BK0096","BK0236","600763","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628785674","title":"图解通策医疗一季报:第一季度单季净利润同比增长1.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628785674","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628785674?lang=zh_cn&edition=full","pubTime":"2026-04-18 01:17","pubTimestamp":1776446250,"startTime":"0","endTime":"0","summary":"证券之星消息,通策医疗2026年一季报显示,一季度公司主营收入7.55亿元,同比上升1.43%;归母净利润1.87亿元,同比上升1.66%;扣非净利润1.85亿元,同比上升1.37%;负债率23.29%,投资收益880.6万元,财务费用823.28万元,毛利率43.87%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041800002644.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628206423","title":"通策医疗(600763.SH)发布2025年度业绩,归母净利润5.02亿元,同比增长0.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628206423","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628206423?lang=zh_cn&edition=full","pubTime":"2026-04-17 20:29","pubTimestamp":1776428972,"startTime":"0","endTime":"0","summary":"智通财经APP讯,通策医疗(600763.SH)发布2025年年度报告,报告期内,公司实现营业收入29.13亿元,同比增长1.37%。实现归属于上市公司股东的净利润5.02亿元,同比增长0.19%。实现归属于上市公司股东的扣除非经常性损益的净利润4.96亿元,同比下降0.04%。基本每股收益为1.12元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430176.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600763"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625939171","title":"通策医疗(600763)披露拟6亿元收购四家眼视光公司股权,4月7日股价上涨0.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625939171","media":"证券之星","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625939171?lang=zh_cn&edition=full","pubTime":"2026-04-07 17:44","pubTimestamp":1775555060,"startTime":"0","endTime":"0","summary":"截至2026年4月7日收盘,通策医疗报收于41.17元,较前一交易日上涨0.44%,最新总市值为184.15亿元。公告显示,公司拟以自有资金60,000万元收购杭州存济眼镜有限公司、宁波广济眼视光科技有限公司、杭州广济眼视光科技有限公司、新昌广济眼镜有限公司100%股权。标的公司为公司实际控制人控制的企业,本次交易构成关联交易。交易对方对标的公司一作出业绩承诺,2026-2028年累计净利润不低于1.8亿元,2026-2030年累计不低于3亿元,并设置现金补偿机制。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700024593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0048","600763","BK0284","BK0077","BK0236","BK0146","BK0096","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625616959","title":"每周股票复盘:通策医疗(600763)拟6亿收购杭州存济眼镜","url":"https://stock-news.laohu8.com/highlight/detail?id=2625616959","media":"证券之星","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625616959?lang=zh_cn&edition=full","pubTime":"2026-04-05 02:06","pubTimestamp":1775325975,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘,通策医疗报收于40.99元,较上周的41.93元下跌2.24%。公司公告汇总通策医疗拟以6亿元现金收购杭州存济眼镜100%股权,标的公司评估值7.03亿元,评估溢价率1282.14%。中联评估关于监管工作函资产评估相关问题的回复浙江中联资产评估有限公司对通策医疗向关联方购买杭州存济眼镜100%股权的资产评估相关问题进行了核查。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040500000444.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0048","600763","BK0284","BK0077","BK0236","BK0146","BK0096","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624507582","title":"通策医疗(600763)披露拟6亿元收购杭州存济眼镜100%股权公告,4月2日股价下跌2.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624507582","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624507582?lang=zh_cn&edition=full","pubTime":"2026-04-02 22:16","pubTimestamp":1775139380,"startTime":"0","endTime":"0","summary":"截至2026年4月2日收盘,通策医疗报收于41.55元,较前一交易日下跌2.19%,最新总市值为185.85亿元。公告显示,公司拟以6亿元现金收购杭州存济眼镜有限公司100%股权,标的公司评估值为7.03亿元,评估溢价率为1282.14%。标的公司2025年净利润为5,558.48万元,静态市盈率为12.65倍。公告同时指出,标的公司部分客源来自关联方浙江广济眼科医院,患者人次占比约40%,存在业务依赖及合作协议到期不续约风险;经营场所由关联方无偿提供。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200042196.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0284","600763","BK0236","BK0096","BK0077","BK0114","BK0048","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621093955","title":"通策医疗(600763)披露2026年独立董事专门会议第一次会议审核意见,3月24日股价上涨1.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621093955","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621093955?lang=zh_cn&edition=full","pubTime":"2026-03-24 22:14","pubTimestamp":1774361669,"startTime":"0","endTime":"0","summary":"截至2026年3月24日收盘,通策医疗报收于41.28元,较前一交易日上涨1.62%,最新总市值为184.64亿元。该股当日开盘41.23元,最高41.37元,最低40.63元,成交额达2.55亿元,换手率为1.39%。近日,通策医疗股份有限公司披露《2026年独立董事专门会议第一次会议的审核意见》公告。公告显示,公司独立董事于2026年3月24日召开2026年独立董事专门会议第一次会议,审阅了本次交易的相关协议、审计报告、评估报告等文件,听取管理层对交易背景、定价依据及未来规划的说明。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400039846.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","BK0048","600763","BK0077","BK0284","BK0096","BK0114","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621066798","title":"通策医疗最新公告:拟6亿元收购四家眼视光公司100%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2621066798","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621066798?lang=zh_cn&edition=full","pubTime":"2026-03-24 19:01","pubTimestamp":1774350092,"startTime":"0","endTime":"0","summary":"通策医疗(600763.SH)公告称,公司拟以自有资金6亿元收购杭州存济眼镜有限公司、宁波广济眼视光科技有限公司、杭州广济眼视光科技有限公司及新昌广济眼镜有限公司100%股权。标的公司均由公司实控人吕建明控制的浙江通策眼科医院投资管理有限公司直接或间接控股,本次交易构成关联交易,不构成重大资产重组,尚需提交股东大会审议。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400033494.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0048","BK0236","BK0077","BK0146","BK0284","600763","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613207194","title":"通策医疗(600763.SH)部分董事及高管拟600万元至1200万元增持公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2613207194","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613207194?lang=zh_cn&edition=full","pubTime":"2026-02-23 16:01","pubTimestamp":1771833670,"startTime":"0","endTime":"0","summary":"智通财经APP讯,通策医疗 发布公告。公司董事、高管拟自本次增持之日起6个月内,以自有资金或自筹资金通过上海证券交易所交易系统以集中竞价交易方式增持公司股份合计不低于600万元,不超过1200万元,本次增持未设置价格区间。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406300.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"通策医疗(600763.SH)部分董事及高管拟600万元至1200万元增持公司股份","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0096","BK0236","BK0114","BK0077","BK0048","600763","BK0146","BK0284"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607048847","title":"1月29日通策医疗涨5.14%,广发聚瑞混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2607048847","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607048847?lang=zh_cn&edition=full","pubTime":"2026-01-29 16:34","pubTimestamp":1769675641,"startTime":"0","endTime":"0","summary":"证券之星消息,1月29日通策医疗涨5.14%,收盘报47.49元,换手率4.62%,成交量20.65万手,成交额9.65亿元。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共8家,其中持有数量最多的公募基金为广发基金的广发聚瑞混合A。广发聚瑞混合A目前规模为16.39亿元,最新净值4.9646,较上一交易日下跌0.64%,近一年上涨32.21%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900026876.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0048","BK0096","BK0114","BK0284","BK0236","600763","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590538210","title":"通策医疗(600763)披露关于选举职工董事及取消职工监事的公告,12月10日股价下跌0.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590538210","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590538210?lang=zh_cn&edition=full","pubTime":"2025-12-10 22:17","pubTimestamp":1765376261,"startTime":"0","endTime":"0","summary":"近日,通策医疗股份有限公司发布关于选举职工董事及取消职工监事的公告。王维倩女士原为非职工董事,本次选举后变更为职工董事,董事会构成人员不变,兼任高级管理人员及职工代表董事人数未超过董事总数的二分之一。公司已根据相关规定取消监事会设置,董事会设职工董事一名。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121000041711.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0284","BK0236","600763","BK0114","BK0146","BK0048","BK0096"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778171520305,"stockEarnings":[{"period":"1week","weight":-0.0097},{"period":"1month","weight":0.0146},{"period":"3month","weight":-0.1599},{"period":"6month","weight":-0.0146},{"period":"1year","weight":0.0267},{"period":"ytd","weight":0.0388}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0745},{"period":"3month","weight":0.0282},{"period":"6month","weight":0.0457},{"period":"1year","weight":0.2505},{"period":"ytd","weight":0.0532}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"通策医疗股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"90510人(较上一季度增加2.32%)","perCapita":"4941股","listingDate":"1996-10-30","address":"浙江省杭州市上城区平海路57号","registeredCapital":"44728万元","survey":" 通策医疗股份有限公司的主营业务是医疗器械、日用品、消毒用品的销售,投资管理,经营进出口业务,技术开发、技术咨询和技术服务,培训服务(不含办培训班)。公司的主要产品是医疗服务、产品销售、建设工程。公司连续七年(2018-2024年)获评德勤中国“中国卓越管理公司”,并于2025年荣膺该评选的“白金奖”、2026年获“杭州上城区经济高质量发展先进集体”,旗下杭州口腔医院荣获2025年度杭州市政府质量奖。","listedPrice":4.08},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"通策医疗(600763)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供通策医疗(600763)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"通策医疗,600763,通策医疗股票,通策医疗股票老虎,通策医疗股票老虎国际,通策医疗行情,通策医疗股票行情,通策医疗股价,通策医疗股市,通策医疗股票价格,通策医疗股票交易,通策医疗股票购买,通策医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"通策医疗(600763)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供通策医疗(600763)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}